Sanofi Pasteur Will Fund Development Of Acambis West Nile Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
Acambis is hoping to accelerate development of ChimeriVax and be first to market with a West Nile vaccine after inking an agreement with Sanofi Pasteur that includes $10 million upfront and $70 million in milestones.